Armelle Dufresne

6.3k total citations · 1 hit paper
103 papers, 2.2k citations indexed

About

Armelle Dufresne is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Rheumatology. According to data from OpenAlex, Armelle Dufresne has authored 103 papers receiving a total of 2.2k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Pulmonary and Respiratory Medicine, 51 papers in Oncology and 27 papers in Rheumatology. Recurrent topics in Armelle Dufresne's work include Sarcoma Diagnosis and Treatment (63 papers), Gastrointestinal Tumor Research and Treatment (18 papers) and Soft tissue tumor case studies (17 papers). Armelle Dufresne is often cited by papers focused on Sarcoma Diagnosis and Treatment (63 papers), Gastrointestinal Tumor Research and Treatment (18 papers) and Soft tissue tumor case studies (17 papers). Armelle Dufresne collaborates with scholars based in France, Canada and United States. Armelle Dufresne's co-authors include Jean‐Yves Blay, Axel Le Cesne, Philippe A. Cassier, Isabelle Ray‐Coquard, Mehdi Brahmi, Sébastien Salas, David Pérol, Olivier Trédan, Thomas Bachelot and Sylvie Chabaud and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Armelle Dufresne

96 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Lymphopenia as a Prognostic Factor for Overall Survival in Advanced Carcinomas, Sarcomas, and Lymphomas

2009 624 citations Isabelle Ray‐Coquard, Axel Le Cesne et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Armelle Dufresne France	19	1.1k	1.1k	793	481	278	103	2.2k
Marta Sbaraglia Italy	21	1.1k 0.9×	557 0.5×	510 0.6×	268 0.6×	175 0.6×	98	1.7k
Vinod Ravi United States	30	1.7k 1.5×	1.6k 1.4×	400 0.5×	321 0.7×	151 0.5×	144	3.0k
Arthur P. Staddon United States	29	2.4k 2.1×	1.4k 1.3×	1.1k 1.4×	426 0.9×	230 0.8×	67	3.5k
Juan C. Gutierrez United States	23	826 0.7×	771 0.7×	406 0.5×	296 0.6×	105 0.4×	31	2.0k
Chiara Colombo Italy	31	2.8k 2.4×	1.3k 1.2×	1.5k 1.9×	736 1.5×	495 1.8×	115	3.6k
Olivier Collard France	16	1.1k 0.9×	681 0.6×	440 0.6×	206 0.4×	106 0.4×	67	1.6k
Bernd Kasper Germany	26	1.8k 1.5×	1.1k 1.0×	858 1.1×	587 1.2×	320 1.2×	171	2.5k
James E. Butrynski United States	26	2.0k 1.8×	1.2k 1.1×	738 0.9×	434 0.9×	444 1.6×	52	3.3k
Uğur Selek Türkiye	26	1.0k 0.9×	958 0.9×	239 0.3×	224 0.5×	170 0.6×	144	2.5k
Angela Cioffi France	22	1.5k 1.3×	958 0.9×	387 0.5×	252 0.5×	343 1.2×	55	2.2k

Countries citing papers authored by Armelle Dufresne

Since Specialization

Citations

This map shows the geographic impact of Armelle Dufresne's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Armelle Dufresne with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Armelle Dufresne more than expected).

Fields of papers citing papers by Armelle Dufresne

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Armelle Dufresne. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Armelle Dufresne. The network helps show where Armelle Dufresne may publish in the future.

Co-authorship network of co-authors of Armelle Dufresne

This figure shows the co-authorship network connecting the top 25 collaborators of Armelle Dufresne. A scholar is included among the top collaborators of Armelle Dufresne based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Armelle Dufresne. Armelle Dufresne is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Vanacker, Hélène, Nicolas Penel, Sarah Watson, et al.. (2025). Clinical and biological factors associated with response to immune checkpoint inhibitors in advanced sarcomas: IMPRESARC, a French retrospective multicenter cohort study. Cancer. 131(18). e70052–e70052. 1 indexed citations

Grillet, Franck, Mehdi Brahmi, Marie Pierre Sunyach, et al.. (2023). Prognostic Factors for Local Recurrence after Cryoablation of Desmoid Tumors. Journal of Vascular and Interventional Radiology. 34(9). 1538–1546. 7 indexed citations

Penel, Nicolas, Sylvie Bonvalot, Marie‐Cécile Le Deley, et al.. (2023). Pain in desmoid‐type fibromatosis: Prevalence, determinants and prognosis value. International Journal of Cancer. 153(2). 407–416. 8 indexed citations

Ray‐Coquard, Isabelle, Jean‐Yves Blay, Armelle Dufresne, et al.. (2023). Efficacy and Safety of Adjuvant Radiotherapy in Re-excised Soft-tissue Sarcoma After Unplanned Resection. The Oncologist. 28(7). 633–639. 5 indexed citations

Brahmi, Mehdi, Olivier Trédan, Nicolas Penel, et al.. (2023). Large versus limited molecular profiling panel screening program in patients with metastatic sarcoma: An exploratory subgroup analysis from the ProfiLER 02 trial.. Journal of Clinical Oncology. 41(16_suppl). 11545–11545. 1 indexed citations

Bini, Marta, Justine Gantzer, Armelle Dufresne, et al.. (2023). ESR1 Rearrangement as a Diagnostic and Predictive Biomarker in Uterine Tumor Resembling Ovarian Sex Cord Tumor: A Report of Four Cases. JCO Precision Oncology. 7(7). e2300130–e2300130. 4 indexed citations

Feng, Xiaolan, Laurie Tonon, Haocheng Li, et al.. (2023). Comprehensive Immune Profiling Unveils a Subset of Leiomyosarcoma with “Hot” Tumor Immune Microenvironment. Cancers. 15(14). 3705–3705. 6 indexed citations

Nassif, Elise F., Édouard Auclin, Rastilav Bahleda, et al.. (2021). TP53 Mutation as a Prognostic and Predictive Marker in Sarcoma: Pooled Analysis of MOSCATO and ProfiLER Precision Medicine Trials. Cancers. 13(13). 3362–3362. 7 indexed citations

Delrieu, Lidia, Marina Touillaud, Olivia Pérol, et al.. (2021). Impact of Physical Activity on Oxidative Stress Markers in Patients with Metastatic Breast Cancer. Oxidative Medicine and Cellular Longevity. 2021(1). 6694594–6694594. 18 indexed citations

10.

Boilève, Alice, Armelle Dufresne, Ali N. Chamseddine, et al.. (2020). Outcomes of patients with metastatic gastrointestinal stromal tumors (GIST) treated with multi-kinase inhibitors other than imatinib as first-line treatment. ESMO Open. 5(6). e001082–e001082. 2 indexed citations

11.

Brahmi, Mehdi, Philippe A. Cassier, Armelle Dufresne, et al.. (2020). Long term term follow-up of tyrosine kinase inhibitors treatments in inoperable or relapsing diffuse type tenosynovial giant cell tumors (dTGCT). PLoS ONE. 15(5). e0233046–e0233046. 9 indexed citations

12.

Sanfilippo, Roberta, Robin L. Jones, Jean‐Yves Blay, et al.. (2019). Role of Chemotherapy, VEGFR Inhibitors, and mTOR Inhibitors in Advanced Perivascular Epithelioid Cell Tumors (PEComas). Clinical Cancer Research. 25(17). 5295–5300. 75 indexed citations

13.

Delrieu, Lidia, Jeff K. Vallance, Magali Morelle, et al.. (2019). Physical activity preferences before and after participation in a 6‐month physical activity intervention among women with metastatic breast cancer. European Journal of Cancer Care. 29(1). e13169–e13169. 15 indexed citations

14.

Delrieu, Lidia, Vincent Pialoux, Olivia Pérol, et al.. (2019). Feasibility and Health Benefits of an Individualized Physical Activity Intervention in Women With Metastatic Breast Cancer: Intervention Study. JMIR mhealth and uhealth. 8(1). e12306–e12306. 40 indexed citations

15.

Delrieu, Lidia, Olivia Pérol, Béatrice Fervers, et al.. (2018). A Personalized Physical Activity Program With Activity Trackers and a Mobile Phone App for Patients With Metastatic Breast Cancer: Protocol for a Single-Arm Feasibility Trial. JMIR Research Protocols. 7(8). e10487–e10487. 20 indexed citations

16.

Crago, Aimeé M., Brian T. Denton, Sébastien Salas, et al.. (2013). A Prognostic Nomogram for Prediction of Recurrence in Desmoid Fibromatosis. Annals of Surgery. 258(2). 347–353. 190 indexed citations

17.

Duffaud, Florence, Caroline Even, Isabelle Ray‐Coquard, et al.. (2012). Recombinant erythropoietin for the anaemia of patients with advanced Gastrointestinal Stromal Tumours (GIST) receiving imatinib: an active agent only in non progressive patients. SHILAP Revista de lepidopterología. 2(1). 11–11. 2 indexed citations

18.

Salas, Sébastien, Armelle Dufresne, Binh Bui, et al.. (2011). Prognostic Factors Influencing Progression-Free Survival Determined From a Series of Sporadic Desmoid Tumors: A Wait-and-See Policy According to Tumor Presentation. Journal of Clinical Oncology. 29(26). 3553–3558. 268 indexed citations

19.

Dufresne, Armelle, et al.. (2008). Vertébroplastie percutanée de la charnière cervico-dorsale par voie antérieure. Technique et résultats. A propos de neuf cas.. Journal of Neuroradiology. 25(2).

20.

Pivot, Xavier, et al.. (2007). Efficacy and Safety of Ixabepilone, a Novel Epothilone Analogue. Clinical Breast Cancer. 7(7). 543–549. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact